Cardiovascular Diseases Clinical Trial
Official title:
Effects of Potted Mint Plants on Indoor Air Quality and the Concentration of Bacterium and Fungus, and Evaluation of Cardiovascular Health
This study will recruit 60 subjects, in sum of 30 families. We will measure 2 indoor environments (living room and bedroom) for All-in-one monitoring the indoor air quality, in which collected culturable fungus and bacteria indoor to calculate colony forming unit (CFU). We will apply Kore Technology (MS-200) (Electron Ionization time-of-flight mass spectrometry, EI-TOF-MS) to measure the indoor volatile organic chemicals (VOCs) before intervention and perform repeated measurements of VOCs and the concentration of phytoncides before intervention and one week later after placing potted plants into indoor environments (living room and bedroom). In conclusion, this study aims to investigate the clinical utility of potted mint plants in reducing indoor bacterial and fungal growth and indoor air pollution, and cardiovascular benefits. Furthermore, the possible application of indoor potted mint plant in antiviral influenza or pneumonia in the future.
The contribution of air pollution is a very important public health issue for human health. Indoor air quality may have more influence on human health than outdoor air pollution. Previous studies indicate indoor air pollution which causes respiratory disease has been associated with cardiovascular disease. Besides, some studies showed that indoor CO2 concentration was positively correlated with virus detection and bacterial concentration in the air, and coagulase-negative staphylococci (CNS) was detected in many poorly ventilated indoor environments. Mint can release chemical substance to inhibit viruses and bacteria. Among the components, the menthol and terpineol induced vasodilation so as to reduce blood pressure. For the pilot study we have finished the qualitative and quantitative research in chemical components released by the mint. Therefore, this study aims to evaluate the indoor air quality and the distribution of fungal and bacterial concentration in the indoor environment, analyze the effect of potted mint plants on indoor air quality, fungal and bacterial concentration, and explore the correlation between the intervention of potted mint plants and cardiovascular health. This study will recruit 60 subjects, in sum of 30 families. We will measure 2 indoor environments (living room and bedroom) for All-in-one monitoring the indoor air quality, in which collected culturable fungus and bacteria indoor to calculate colony forming unit (CFU). We will apply Kore Technology (MS-200) (Electron Ionization time-of-flight mass spectrometry, EI-TOF-MS) to measure the indoor volatile organic chemicals (VOCs) before intervention and perform repeated measurements of VOCs and the concentration of phytoncides before intervention and one week later after placing potted plants into indoor environments (living room and bedroom). Furthermore, we used matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF-MS) to identify microbiology; simultaneously, we record the outdoor environment and indoor ventilation. To assess subjects' cardiovascular health, we use DynaPulse to evaluate their cardiovascular function, and make them equipped with Holter electrocardiography (ECG) to continuously monitor the trend of heart rate variability (HRV) before and after intervention. In conclusion, this study aims to investigate the clinical utility of potted mint plants in reducing indoor bacterial and fungal growth and indoor air pollution, and cardiovascular benefits. Furthermore, the possible application of indoor potted mint plant in antiviral influenza or pneumonia in the future. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|